Trial
NCT05924594
Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301
Phase IIISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Cingulate Therapeutics
Collaborators
—
Condition
ADHD
Intervention
CTx-1301 - Dexmethylphenidate 6.25mg
Why stopped
Continuation of the study is not required for NDA submission via the 505(b)(2) pathway
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-05